BamSEC and AlphaSense Join Forces
Learn More

Theravance Biopharma Inc.

NASDAQ: TBPH    
Share price (1/8/25): $9.05    
Market cap (1/8/25): $445 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 184 pages Indenture Dated as of February 28, 2020 by and Among Triple Royalty Sub II LLC, a Delaware Limited Liability Company, as Issuer of the Notes Described Herein, U.S. Bank National Association, a National Banking Association, as Initial Trustee, Transfer Agent, Paying Agent, Registrar and Calculation Agent of the Notes Described Herein and Solely With Respect to Section 2.11(o) and Section 2.11(p) Theravance Biopharma, Inc
12/34/56
EX-4.10
from 10-K 10 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3ASR 50 pages Theravance Biopharma, Inc. [ ] Trustee Indenture Dated as of [ ] Theravance Biopharma, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of [ ]
12/34/56
EX-4.1
from 8-K 194 pages Indenture Dated as of November 30, 2018 by and Between Triple Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes Described Herein, and U.S. Bank National Association, a National Banking Association, as Initial Trustee, Transfer Agent, Paying Agent, Registrar and Calculation Agent of the Notes Described Herein
12/34/56
EX-4.2
from 8-K 4 pages Amendment and Termination of Rights Agreement
12/34/56
EX-4.2
from 8-K 82 pages Theravance Biopharma, Inc. 3.25% Convertible Senior Notes Due 2023 First Supplemental Indenture Dated as of November 2, 2016 Wells Fargo Bank, National Association as Trustee
12/34/56
EX-4.1
from 8-K 75 pages Theravance Biopharma, Inc. as Issuer and Wells Fargo Bank, National Association, as Trustee Trustee Indenture Dated as of November 2, 2016 Theravance Biopharma, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of November 2, 2016
12/34/56
EX-4.5
from S-3ASR 47 pages Theravance Biopharma, Inc. as Issuer and Wells Fargo Bank, National Association, as Trustee Trustee Indenture Dated as of [ ] Theravance Biopharma, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of [ ]
12/34/56
EX-4.1
from 8-K 8 pages First Amendment to Rights Agreement
12/34/56
EX-4.4
from S-3 52 pages Theravance Biopharma, Inc. as Issuer Certain Guarantors and [ ] Trustee Indenture Dated as of [ ] Theravance Biopharma, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of [ ]
12/34/56
EX-4.3
from S-3 46 pages Theravance Biopharma, Inc. and Computershare Inc., as Rights Agent Rights Agreement Dated as of May 9, 2014 Rights Agreement
12/34/56
EX-4.3
from 10-12B/A 46 pages Theravance Biopharma, Inc. and Computershare Inc., as Rights Agent Rights Agreement Dated as of , 2014 Rights Agreement
12/34/56
EX-4.1
from 10-12B/A 1 page Indenture or similar
12/34/56
EX-4.3
from 10-12B/A 46 pages Theravance Biopharma, Inc. and Computershare Inc., as Rights Agent Rights Agreement Dated as of , 2014 Rights Agreement
12/34/56
EX-4.2
from 10-12B/A 17 pages Theravance Biopharma, Inc. Registration Rights Agreement March 3, 2014
12/34/56